AzTrials
AzTrials

Gestational Diabetes Mellitus in PregnancyNCT06021691

Gestational Diabetes Mother-infant Cohort

An observational study of Gestational Diabetes Mellitus in Pregnancy and Cognitive Impairment, run by Gansu Provincial Maternal and Child Health Care Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The bi-directional dynamic cohort study is to learn about the effects of prenatal exposure to high blood glucose levels and postnatal nurturing environment factors on delayed language development in children. Read more about this study

Who is it for?
Ages 1 year to 3 yearsHealthy volunteers can take part
What is being tested?
Acquired nurturing environment
How many people
600 participants
Where
1 siteChina
Study dates
1 Feb 2023to 30 Nov 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 3 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: The pregnant women with abnormal blood glucose levels and the offspring

Who may be able to join

  • Children 1.5-2.5 years old with no serious underlying diseases and no hearing impairment.

Who cannot join

  • diagnosed hearing impairment, organic dysarthria, oral disease; (ii) cerebral palsy;
  • neurological and hereditary metabolic diseases; (iv) deaf father/mother.

Trial locations and contacts

1 site in 1 country.

Yanxia Wang, Dr. contact

86-0931-5188689

1091771450@qq.com

China1 site, 1 recruiting
  • GansuPMCH

    Lanzhou, Gansu, 730050

    Yanxia Wang, Dr., 13893210796, 1091771450@qq.com

    Recruiting

Other trials in China

About this study

Official title: A Cohort Study on the Impact of Gestational Blood Glucose Management and Postnatal Nurturing Environment on Delayed Language Development in Children

The bi-directional dynamic cohort study is to learn about the effects of prenatal exposure to high blood glucose levels and postnatal nurturing environment factors on delayed language development in children. The study investigated the results of blood glucose screening during pregnancy for the children's mothers, and followed up on the blood glucose management effectiveness of pregnant women with abnormal blood glucose levels before delivery. Participants will be also surveyed the "S-S method for language development assessment, "gsell Scale", and "0-6 year-old family nurturing environment evaluation scale" to evaluate the language development and family nurturing environment.

Read the detailed description

Glucose management during pregnancy and the postnatal nurturing environment are keys to early detection and early intervention of language delay, which is important to reduce abnormal language development in children. In this study, mothers diagnosed with gestational diabetes mellitus in the department of hospital and offspring were used as participants. The investigators take a follow-up visit to participants' offspring using the S-S method of language development assessment, gsell Infant and Toddler Development Scale, and 0-6 years old family parenting environment evaluation scale. The bi-directional dynamic cohort study is to learn about the effects of prenatal exposure to high blood glucose levels and postnatal nurturing environment factors on delayed language development in children.

Being tested
Acquired nurturing environment
Keywords
Child cognitive impairment, Intrauterine high-glucose environment, Acquired nurture environment
Medical subject headings
Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Acquired nurturing environmentBehavioural

    Superimposed effects of intrauterine high-sugar environment exposure and postnatal nurturing environment exposure

Study groups in NCT06021691
Study groupRoleWhat they receive
Gestational diabetes offspring cohortThe Gestational diabetes(GDM) offspring cohort is to learn about language development assessment in 2-year-old children and causal association with their mother who diagnosed GDM
Receives: Behavioral: Acquired nurturing environment
Healthy maternal offspring cohortHealthy maternal offspring cohort is to learn about language development assessment in 2-year-old children and causal association with their health mother
Receives: Behavioral: Acquired nurturing environment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. delayed language development in children

    "Number of participants diagnosed with GDM," "Number of offspring of participants who participated in the survey of family nurturing environments," and "Composition ratio of offspring with GDM who presented with language delays."

    Measured: 2023.1-2025.11

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Sep 2023
  2. Study start1 Feb 2023
  3. Primary completion30 Nov 2025 (estimated)
  4. Study completion30 Nov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06021691
Sponsor's protocol ID
NCRCCHD-2022-GP-17
Status last verified
Aug 2023
First submitted
7 Jun 2023
Last updated
1 Sep 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Gestational Diabetes Mellitus in Pregnancy and Cognitive Impairment, run by Gansu Provincial Maternal and Child Health Care Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yanxia Wang, Dr. (86-0931-5188689, 1091771450@qq.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

delayed language development in children (time frame: 2023.1-2025.11). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in